Park Place Capital Corp Laboratory Corp Of America Holdings Transaction History

Park Place Capital Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$209.01 - $232.56 $35,740 - $39,767	-171 Reduced 49.71%	173 $37,000
Q4 2023 Jan 24, 2024	SELL	$197.69 - $227.29 $10,082 - $11,591	-51 Reduced 12.91%	344 $78,000
Q3 2023 Oct 17, 2023	BUY	$201.05 - $221.7 $22,919 - $25,273	114 Added 40.57%	395 $79,000
Q2 2023 Aug 04, 2023	SELL	$211.93 - $241.33 $635 - $723	-3 Reduced 1.06%	281 $67,000
Q1 2023 May 02, 2023	BUY	$213.32 - $257.83 $1,919 - $2,320	9 Added 3.27%	284 $65,000
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $56,023 - $68,466	275 New	275 $65,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Park Place Capital Corp with notifications on news.